Brennan, Manna & Diamond
Listen. Solve. Empower.
Diversity & Inclusion
Client Alerts, News Articles, Blog Posts, & Multimedia
Everything you need to know about BMD and the industry.
HHS Addresses Drug Manufacturer Coupons on Out-of-Pocket Limits
May 25, 2020
On May 7, 2020, the US Department of Health and Human Services (“HHS”) announced their Notice of Benefit Parameters for 2021 in which HHS addressed the application of prescription drug manufacturer copay coupons towards a patient’s out-of-pocket limit. Under this guidance, HHS will permit, but not require, plans and insurers to count direct support offered to enrollees by drug manufacturers (i.e., coupons) for specific prescription drugs toward the annual limits on cost-sharing, regardless of whether a generic equivalent is available.
Kevin M. Cripe